For once, it's the U.S. that's following the European Union in issuing new sanctions on Russia in retaliation for its role in stoking violence in Ukraine
The fast-food business model just suffered a blow, and it could change everything from unionization to wages
The federal government won't join many so-called qui tam cases; when it does, financial rewards for whistleblowers will most likely be small
Virtual currencies backed by gold try to offer the convenience of Bitcoin without the Bitcoin risk
Twitter's results weren't that much different from last quarter's. The big difference: expectations
A closer look at five of the 81 indicators that researchers use to rank nations in the Global Innovation Index
The chain is exploring opportunities in craft beer and making a greater emotional connection with diners
Thanks to a quirk in Federal law, most students of the company's shuttered for-profit schools can't do anything about their student debt.
Cities including Seattle and San Diego are eyeing higher wage floors
Founders: Cam Garner, Elaine Phillips, Malcolm Hill, and Adam Simpson
VC Investment over the last four quarters: $22.5 million
Founded in 2008, this nine-employee drug company develops products for the treatment of allergic inflammation of the gastrointestinal tract. "We identified a market that we believe has a true unmet medical need—in this particular instance there is no product approved by the FDA for the treatment of eosinophilic esophagitis," says a Meritage spokesperson in an e-mail. In the midst of the recession, its founders say that it is particularly important to stay focused on execution.
Key to startup success: "If we are able to successfully develop safe and effective products to meet the unmet medical needs of patients and their caregivers, we believe that capital will continue to be available."